A genetic researcher's devil's dilemma: Warn relatives about their genetic risk or respect confidentiality agreements with research participants?
- PMID: 34814911
- PMCID: PMC8609755
- DOI: 10.1186/s12910-021-00721-4
A genetic researcher's devil's dilemma: Warn relatives about their genetic risk or respect confidentiality agreements with research participants?
Abstract
Background: With advances in sequencing technologies, increasing numbers of people are being informed about a genetic disease identified in their family. In current practice, probands (the first person in a family in whom a genetic predisposition is identified) are asked to inform at-risk relatives about the diagnosis. However, previous research has shown that relatives are sometimes not informed due to barriers such as family conflicts. Research on family communication in genetic diseases aims to explore the difficulties encountered in informing relatives and to identify ways to support probands in this.
Main body: Research on family communication may also reveal that participants did not inform their relatives about the risk of a serious genetic condition, even when preventive and treatment options are available. Researchers may then face a dilemma: Do they need to warn at-risk relatives about the finding? Or do they keep silent due to prior confidentiality agreements with study participants?
Conclusions: We believe that the absolute confidence promised to research participants outweighs the interests of their relatives, even though it can be claimed that relatives at risk of a genetic disease do, in principle, have a right to know information collected about their health. Not respecting confidentiality agreements could cause distrust between researchers and research participants and possibly harm the relationship between probands and relatives. Relatives' health interests can still be taken into account without jeopardizing participant trust, by considering alternative scenarios, including sharing general study findings on the barriers participants experience with their healthcare professionals and by offering participants psychosocial support for family communication.
Keywords: Duty to warn; Family communication research; Genetic risk; Informing at-risk relatives.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
The duty to warn at-risk relatives-The experience of genetic counselors and medical geneticists.Am J Med Genet A. 2020 Feb;182(2):314-321. doi: 10.1002/ajmg.a.61425. Epub 2019 Dec 8. Am J Med Genet A. 2020. PMID: 31814270
-
The "duty to warn" a patient's family members about hereditary disease risks.JAMA. 2004 Sep 22;292(12):1469-73. doi: 10.1001/jama.292.12.1469. JAMA. 2004. PMID: 15383518
-
How to inform at-risk relatives? Attitudes of 1379 Dutch patients, relatives, and members of the general population.J Genet Couns. 2020 Oct;29(5):786-799. doi: 10.1002/jgc4.1206. Epub 2019 Dec 30. J Genet Couns. 2020. PMID: 31889383 Free PMC article.
-
How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes.J Genet Couns. 2019 Oct;28(5):1042-1058. doi: 10.1002/jgc4.1143. Epub 2019 Jun 19. J Genet Couns. 2019. PMID: 31216099
-
Informing relatives of their genetic risk: an examination of the Belgian legal context.Eur J Hum Genet. 2022 Jul;30(7):766-771. doi: 10.1038/s41431-021-01016-3. Epub 2022 Jan 8. Eur J Hum Genet. 2022. PMID: 34997232 Free PMC article. Review.
Cited by
-
Navigating family dynamics and ethical considerations in genetic diagnosis of pulmonary arterial hypertension: insights from in-depth semi-structured interviews.ERJ Open Res. 2025 Mar 24;11(2):00698-2024. doi: 10.1183/23120541.00698-2024. eCollection 2025 Mar. ERJ Open Res. 2025. PMID: 40129555 Free PMC article.
-
Utilization of genetic information for medicines development and equitable benefit sharing.Front Genet. 2023 Jun 14;14:1085864. doi: 10.3389/fgene.2023.1085864. eCollection 2023. Front Genet. 2023. PMID: 37388927 Free PMC article.
References
-
- Menko FH, Jeanson KN, Bleiker EMA, van Tiggelen CWM, Hogervorst FBL, Ter Stege JA, et al. The uptake of predictive DNA testing in 40 families with a pathogenic BRCA1/BRCA2 variant. An evaluation of the proband-mediated procedure. Eur J Hum Genet. 2020;28:1020–1027. doi: 10.1038/s41431-020-0618-8. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical